![Sachiyo Minegishi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sachiyo Minegishi
Directeur des opérations chez
Rectify Pharmaceuticals LLC
Profil
Sachiyo Minegishi is currently Chief Operating Officer at Rectify Pharmaceuticals LLC since 2023.
Former positions include Independent Director at Mural Oncology Plc from 2024 to 2025, Vice President at bluebird bio, Inc. from 2016 to 2020, Senior Director-US Cardiology Rare Disease at Aegerion Pharmaceuticals, Inc. from 2012 to 2016, and Chief Financial Officer at Akouos, Inc. Education includes an undergraduate degree from Massachusetts Institute of Technology and an MBA from The Wharton School of the University of Pennsylvania.
Postes actifs de Sachiyo Minegishi
| Sociétés | Poste | Début |
|---|---|---|
Rectify Pharmaceuticals LLC
 Rectify Pharmaceuticals LLC BiotechnologyHealth Technology Operates as a biotechnology company that develops positive functional modulators | Directeur des opérations | 01/04/2023 |
Anciens postes connus de Sachiyo Minegishi
| Sociétés | Poste | Fin |
|---|---|---|
| GENETIX BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01/09/2020 |
| AEGERION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/04/2016 |
| AKOUOS | Directeur Financier/CFO | - |
Formation de Sachiyo Minegishi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
36
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akouos, Inc.
 Akouos, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a genetic medicine company that develops adeno-associated viral vector-based gene therapies for sensorineural hearing loss | Commercial Services |
Rectify Pharmaceuticals LLC
Rectify Pharmaceuticals LLC BiotechnologyHealth Technology Operates as a biotechnology company that develops positive functional modulators | Health Technology |
